BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 28433750)

  • 21. In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan.
    Fernández-Ferreiro A; González Barcia M; Gil-Martínez M; Vieites-Prado A; Lema I; Argibay B; Blanco Méndez J; Lamas MJ; Otero-Espinar FJ
    Eur J Pharm Biopharm; 2015 Aug; 94():342-51. PubMed ID: 26079831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of gellan gum on the thermogelation property and drug release profile of Poloxamer 407 based ophthalmic formulation.
    Dewan M; Sarkar G; Bhowmik M; Das B; Chattoapadhyay AK; Rana D; Chattopadhyay D
    Int J Biol Macromol; 2017 Sep; 102():258-265. PubMed ID: 28390828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of Ocular In Situ Gelling Properties of Low Acyl Gellan Gum by Use of Ion Exchange.
    Reed K; Li A; Wilson B; Assamoi T
    J Ocul Pharmacol Ther; 2016 Nov; 32(9):574-582. PubMed ID: 27611484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
    Verma P; Gupta RN; Jha AK; Pandey R
    Drug Deliv; 2013; 20(7):269-76. PubMed ID: 24044644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel.
    Kesarla R; Tank T; Vora PA; Shah T; Parmar S; Omri A
    Drug Deliv; 2016 Sep; 23(7):2363-2370. PubMed ID: 25579467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ion-activated
    Lavania K; Garg A
    Recent Adv Drug Deliv Formul; 2024; 18(1):35-49. PubMed ID: 38058093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposome incorporated ion sensitive in situ gels for opthalmic delivery of timolol maleate.
    Yu S; Wang QM; Wang X; Liu D; Zhang W; Ye T; Yang X; Pan W
    Int J Pharm; 2015 Mar; 480(1-2):128-36. PubMed ID: 25615987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of physicochemical properties of nanocolloidal carrier loaded with cyclosporine for topical treatment of psoriasis: in vitro diffusion and in vivo hydrating action.
    Musa SH; Basri M; Fard Masoumi HR; Shamsudin N; Salim N
    Int J Nanomedicine; 2017; 12():2427-2441. PubMed ID: 28405165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nose-to-brain delivery of teriflunomide-loaded lipid-based carbopol-gellan gum nanogel for glioma: Pharmacological and in vitro cytotoxicity studies.
    Gadhave D; Rasal N; Sonawane R; Sekar M; Kokare C
    Int J Biol Macromol; 2021 Jan; 167():906-920. PubMed ID: 33186648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system.
    Geethalakshmi A; Karki R; Jha SK; Venkatesh DP; Nikunj B
    Curr Drug Deliv; 2012 Mar; 9(2):197-204. PubMed ID: 22283647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
    Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C
    Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide.
    Abdel-Rashid RS; Helal DA; Omar MM; El Sisi AM
    Int J Nanomedicine; 2019; 14():2973-2983. PubMed ID: 31118616
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of xanthan gum and guar gum on in situ gelling ophthalmic drug delivery system based on poloxamer-407.
    Bhowmik M; Kumari P; Sarkar G; Bain MK; Bhowmick B; Mollick MM; Mondal D; Maity D; Rana D; Bhattacharjee D; Chattopadhyay D
    Int J Biol Macromol; 2013 Nov; 62():117-23. PubMed ID: 23988556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits.
    Mishra V; Jain NK
    Int J Pharm; 2014 Jan; 461(1-2):380-90. PubMed ID: 24291772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery system.
    Sayed EG; Hussein AK; Khaled KA; Ahmed OA
    Drug Des Devel Ther; 2015; 9():1427-35. PubMed ID: 25792803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gel-embedded niosomes: preparation, characterization and release studies of a new system for topical drug delivery.
    Coviello T; Trotta AM; Marianecci C; Carafa M; Di Marzio L; Rinaldi F; Di Meo C; Alhaique F; Matricardi P
    Colloids Surf B Biointerfaces; 2015 Jan; 125():291-9. PubMed ID: 25524220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.
    Wu C; Qi H; Chen W; Huang C; Su C; Li W; Hou S
    Yakugaku Zasshi; 2007 Jan; 127(1):183-91. PubMed ID: 17202799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levofloxacin Hemihydrate In Situ Gelling Ophthalmic Solution: Formulation Optimization and In Vitro and In Vivo Evaluation.
    Bhalerao H; Koteshwara KB; Chandran S
    AAPS PharmSciTech; 2019 Aug; 20(7):272. PubMed ID: 31372767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gellan gum and its methacrylated derivatives as in situ gelling mucoadhesive formulations of pilocarpine: In vitro and in vivo studies.
    Agibayeva LE; Kaldybekov DB; Porfiryeva NN; Garipova VR; Mangazbayeva RA; Moustafine RI; Semina II; Mun GA; Kudaibergenov SE; Khutoryanskiy VV
    Int J Pharm; 2020 Mar; 577():119093. PubMed ID: 32004682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nimodipine Ophthalmic Formulations for Management of Glaucoma.
    Maria DN; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Pharm Res; 2017 Apr; 34(4):809-824. PubMed ID: 28155073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.